Exchange Bulletin
Titan Medical Inc. (TMD) To Trade On Toronto Stock Exchange
September 29, 2014
Titan Medical Inc. (the "Company") – An application has been granted for the original listing in the Industrial category of 144,839,817 common shares of the Company (the "Shares"), of which 101,802,839 are issued and outstanding and 43,036,978 are reserved for issuance.
An application has also been granted for the original listing of:
- 3,665,900 Share purchase warrants (the "December 2015 Warrants"), all of which are issued and outstanding, each December 2015 Warrant entitling the holder to purchase one Share at a price of $1.85 at any time until 5:00 p.m. (Toronto time) on December 10, 2015;
- 5,121,500 Share purchase warrants (the "June 2016 Warrants"), all of which are issued and outstanding, each June 2016 Warrant entitling the holder to purchase one Share at a price of $2.00 at any time until 5:00 p.m. (Toronto time) on June 21, 2016;
- 4,184,500 Share purchase warrants (the "December 2016 Warrants"), all of which are issued and outstanding, each December 2016 Warrant entitling the holder to purchase one Share at a price of $1.75 at any time until 5:00 p.m. (Toronto time) on December 22, 2016;
- 5,302,705 Share purchase warrants (the "March 2018 Warrants"), all of which are issued and outstanding, each March 2018 Warrant entitling the holder to purchase one Share at a price of $1.25 at any time until 5:00 p.m. (Toronto time) on March 13, 2018;
- 8,317,856 Share purchase warrants (the "February 2017 Warrants"), all of which are issued and outstanding, each February 2017 Warrant entitling the holder to purchase one Share at a price of $2.00 at any time until 5:00 p.m. (Toronto time) on February 19, 2017; and
- 12,296,414 Share purchase warrants (the "April 2017 Warrants" and, collectively with the Shares, the December 2015 Warrants, June 2016 Warrants, December 2016 Warrants, March 2018 Warrants, and February 2017 Warrants, the "Securities"), all of which are issued and outstanding, each April 2017 Warrant entitling the holder to purchase one Share at a price of $2.75 at any time until 5:00 p.m. (Toronto time) on April 23, 2017;
The Securities will be listed and posted for trading at the opening of business on Tuesday, September 30, 2014.
The Company will be subject to the reporting requirements of Section 501 of the TSX Company Manual.
Shares:
| Stock Symbol: "TMD" | CUSIP: 88830X 10 8 | Trading Currency: CDN $ |
December 2015 Warrants:
| Stock Symbol: "TMD.WT" | CUSIP: 88830X 11 6 | Trading Currency: CDN $ |
June 2016 Warrants:
| Stock Symbol: "TMD.WT.A" | CUSIP: 88830X 12 4 | Trading Currency: CDN $ |
December 2016 Warrants:
| Stock Symbol: "TMD.WT.B" | CUSIP: 88830X 13 2 | Trading Currency: CDN $ |
March 2018 Warrants:
| Stock Symbol: "TMD.WT.C" | CUSIP: 88830X 17 3 | Trading Currency: CDN $ |
February 2017 Warrants:
| Stock Symbol: "TMD.WT.D" | CUSIP: 88830X 18 1 | Trading Currency: CDN $ |
April 2017 Warrants:
| Stock Symbol: "TMD.WT.E" | CUSIP: 88830X 19 9 | Trading Currency: CDN $ |
| Temporary Market Maker: | JitneyTrade Inc. |
| Other Markets: | The Shares have been listed on TSX Venture Exchange since July 30, 2008. The warrants were listed on TSX Venture Exchange as follows: the December 2015 Warrants were listed on December 30, 2010, the June 2016 Warrants were listed on August 2, 2011, the December 2016 Warrants were listed on January 23, 2012, the March 2018 Warrants were listed on March 25, 2013, the February 2017 Warrants were listed on March 28, 2014 and the April 2017 Warrants were listed on May 7, 2014 (collectively, the "Warrants"). |
| The Shares and Warrants will be delisted from TSX Venture Exchange on Tuesday, September 30, 2014, upon commencement of trading on Toronto Stock Exchange ("TSX"). | |
| Head Office Address: | 170 University Avenue, Suite 1000 Toronto, Ontario M5H 3B3 |
| Email Address: | stephen@titanmedicalinc.com |
| Website: | www.titanmedicalinc.com |
| Head Office Telephone Number: | (416) 548-7522 ext.152 |
| Investor Relations: | Sherry L. Bertner Bertner Advisors, LLC (347) 565-4258 sherry.bertner@bertneradvisors.com |
| Incorporation: | The Company is the successor corporation formed pursuant to two separate amalgamations under the Business Corporations Act (Ontario) on July 28, 2008. |
| Fiscal Year End: | December 31 |
| Chief Financial Officer and Corporate Secretary: |
Stephen Randall |
| Nature of Business: | The Company's business is focused on the research and development of robotic surgical technologies for application in minimally invasive surgery. |
| Transfer Agent & Registrar: | Computershare Trust Company of Canada |
| Dividends: | The Company currently intends to retain any future earnings to fund the expansion and growth of its business and does not anticipate paying any dividend in the foreseeable future. |
